powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1093074106
Nicholas Mcandrew
M.D.
Hematology-Oncology
Los Angeles,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 050112
Hospital
CCN 050262
Hospital
CCN 050625
Hospital
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
79.4
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
348
Beneficiaries
—
Total drug cost
$205K
Distinct drugs
7
Brand share
6.3%
Top prescribed drugs
Anastrozole
191 claims
Tamoxifen Citrate
64 claims
Ribociclib Succinate
22 claims
Letrozole
21 claims
Exemestane
20 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
15
By payment type
Consulting Fee
$3K
Food and Beverage
$913
Top paying entities
Consulting Fee
$3K
Food and Beverage
$913
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
640
Unique beneficiaries
—
Total services
1,806
Distinct HCPCS
18
Medicare payment
$89K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — above median (cohort median 4,173).
